Loading
Latest filing published 24 Jan 2025 for Zhongzhi Pharmaceutical Holdings Ltd., €6,352. Read the official filing
Based on 27 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jiang Li Xia is a declared insider of Zhongzhi Pharmaceutical Holdings Ltd., with filings sourced from HKEX. The record holds 28 filings, for trades running from 14 May 2018 to 23 January 2025.
Market trades split into 27 purchases (€4.6M) and 1 sale. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 5 purchases and no sales on the market.
A typical purchase (the median) is worth €79k. 23 out of 27 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 27 purchases show a median change of -5.9%, with the price up in 22% of them. Past outcomes like these are no guarantee of what comes next.
On 24 January 2025 came the latest disclosure, an open-market purchase for €6,352 in Zhongzhi Pharmaceutical Holdings Ltd. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations